Trial reportObesity (Silver Spring, Md.)2026
Weight Loss Improves Predicted 10-Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year.
Trial report in Obesity (Silver Spring, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00067873 (Exercise Training in Obesity-prone Black and White Women), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Exercise Training in Obesity-prone Black and White Women
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThis study aimed to quantify changes in predicted 10-year risk for major adverse cardiovascular events (MACE) and type 2 diabetes (T2D) across weight loss, post-weight loss (Post-WL), and 1-year follow-up and to determine whether trajectories varied by exercise modality.
methodsSedentary women with overweight (21-49 years) were randomized to Diet+Aerobic, Diet+Resistance, or Diet-only and completed an 800 kcal/day diet until BMI < 25 kg m
resultsAmong 221 women (115 African American), mean BMI decreased from 28.3 to 23.9 kg m
conclusionsWeight loss reduced MACE and T2D risks, but both rebounded with weight regain. Resistance exercise may be beneficial in weight loss interventions to prevent progression to T2D.
trial registrationClinicalTrials.gov identifier: NCT00067873.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.